The 3rd
Diabetes Innovation Summit
for HCPs in 2025
You are invited to be a part of the distinctive future of Diabetes
The Second Diabetes Innovation Summit for Healthcare Professionals in Central & Eastern Europe, Middle East & Africa
January 24 & 25, 2025 Istanbul, Türkiye
Location
The event will take place in Hilton Istanbul Bakirkoy hotel. One of the largest metropols in the world, İstanbul is a strategical intersection point for almost everything. This distinctive city is one of the best options to host distinctive people at a special event.
Why Distinct?
We are the global healthcare technology leader, with more than 90,000 people across 150 countries. We innovate solutions that treat more than 70 health conditions, from Parkinson’s to diabetes. And while our healthcare technologies transform the lives of two people every second, every hour, of every day, expect more from us. We keep expanding our impact far beyond. In everything we do, we are engineering the extraordinary.
The rich history of diabetes within Medtronic is a distinctive story itself. This event will host the most distinctive healthcare professionals with the most innovative content. As this is the second Diabetes Innovation Summit organized by Medtronic, we are already thrilled to be sharing knowledge and expanding the opportunities about the future of diabetes. This extraordinary event needed an extraordinary name to tell its story.
Extraordinary evolution in Medtronic Diabetes technology
Get to know our faculty of speakers
World-class elite speakers will share their knowledge during Distinct 2025
Coming soon
Download the agenda
We know that in diabetes every minute counts.That’s why we designed a distinctive program to contribute to the efficiency of innovative learning.
Coming soon
Technology that transforms lives
Get to know Medtronic Diabetes therapies
MiniMed™ 780G system with Simplera Sync™ sensor
More Time in Range1*, day and night.
The MiniMed™ 780G system automatically** adjusts insulin delivery and corrects glucose levels every 5 minutes 24/7.
Now with Simplera Sync™ sensor—an all-in-one, easy to apply sensor, requiring no finger pricks***
for Insulin Pumps
Designed for everybody and every lifestyle.
- Medtronic’s wide range of infusion sets aims to provide patients with the possibility to select the right infusion set for their comfort and safety. This selection should be based on your lifestyle, age, body type, preferences and clinical recommendations.
- Medtronic Reservoirs are also available in 1.8 ml and 3.0 ml sizes in order to meet daily insulin needs.
Medtronic infusion sets
and reservoir
Carelink™ system
Enabling diabeter management in your clinic
- Personalise your individual patients’ glucose settings
- Simplified data viewing. Faster insights.
- Meaningful data at a glance.
- Comprehensive report for in-depth analysis
- Help patients see a more complete picture
Smart MDI system
Take the guesswork out of insulin dosing† with the Smart MDI system
The Smart MDI system combines the power of our latest innovation in continuous glucose monitoring (CGM), Simplera™ CGM with the InPen™ Smart Insulin Pen.
The InPen™ smart insulin pen is designed to assist with tracking of insulin doses, dosing recommendations and missed dose alerts.
Simplera™ CGM helps you to know before you go low or high with real- time glucose readings, trends and alerts without finger pricks.‡
i-Port Advance™
Let’s reduce the anxiety of injections together.2
- i-Port Advance is a subcutaneous injection port enabling the user to administer multiple daily injections.
- It can be worn for up to 72 hours§ thus may reduce the number of skin punctures related to administration from an average of 4-6 per day to just one every 3 days. i-Port Advance is for patients who want to reduce the intrusion of injections on daily life.
References
- Choudary P, et al. Diabetes Technol Ther 2024; 26 (Suppl. 3): S32-S37.
- Riley D, Raup G. Impact of a subcutaneous injection device on improving patient care. Nurs Manage. 2010;41(6):49-54
* Compared to MDI + isCGM
** Refer to System User Guide - SmartGuard™ feature. Some user interaction required
*** A blood glucose (BG) reading is needed when entering SmartGuard™ feature. If glucose alerts and CGM readings do not match your symptoms, use a BG meter to make diabetes treatment decisions. Refer to System User Guide - SmartGuard™ feature. Some user interaction required
† Dosing recommendation calculated as per HCP initial settings and users estimated carbohydrates amount
‡ If CGM readings do not match SG or expectations, use a blood glucose meter to make diabetes treatment decisions. Refer to System User Guide
§ Do not inject more than 75 times through a single device. This information does not substitute the Instructions for Use/User Guide. For a listing of indications, contraindications, precautions, warnings, and potential adverse events, please refer to the Instructions for use.